Manning Selvage & Lee CEO Mark Hass goes On the Record…Online at the 2008 PRSA International Conference about MS&L’s strategy for penetrating China, his acquisition strategy for buying new firms and what it takes to be a managing director at MS&L.
Mark Hass, CEO of Manning Selvage & Lee has held this position since April 2005. In this role, Hass leads MS&L and its global leadership team, and acts as a strategic counselor to the firm’s largest clients, including General Motors, Philips and Procter & Gamble. Hass joined MS&L in 2002, when his public relations agency, Hass Associates, was acquired and merged into MS&L. As CEO of Hass Associates, then Michigan’s largest PR firm, he was a senior counsel to GM, and a key consultant for Chrysler Corp.
2:42 – Hass on his keynote speech at the 2008 PRSA International Conference.
3:46 – Hass on how new media is changing the public relations industry.5:50 – Hass on how to convince board rooms that social media is important.
8:41 – Hass on the relationship between stock price and new media adoption rates.
9:13 – Hass on Google’s big secret.
11:07 – Hass on the future of media relations as a PR agency revenue driver.
12:42 – Hass on reinventing the business of public relations.
14:09 – Hass on the economic future for MS&L.
17:07 – Hass on emerging PR markets.
18:51 – Hass on penetrating emerging markets like China and India.
22:38 – Hass gives advice on what he looks for in a new PR hire.
24:26 – End
Eric Schwartzman is the founder of online newsroom management service iPressroom and creator of the New Media PR Boot Camp, which has been attended by over a thousand public relations and marketing executives from private, public, government and nonprofit sectors.
PR Tech Wednesdays
Strategic communicators share insights on where we the industry every Wednesday from 12-1pm Pacific Time
And I hate self help books. In fact, if there was such a thing as self help…
Everyone in B2B is talking about aligning sales, marketing and customer service to better serve buyers. As…
To eradicate a disease, treat the symptom, but eliminate the cause. For the first time, when it…